This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Ensign Group (ENSG) Up 13.4% Since Last Earnings Report?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ENSG Gains 3% on Q1 Earnings Beat, Higher Patient Days Aid
by Zacks Equity Research
Ensign Group's first-quarter results gain on improved skilled services revenues and higher rental revenues. Management projects 2025 adjusted EPS to be within $6.22-$6.38.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ensign Group (ENSG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Ensign Group (ENSG) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ensign Group (ENSG) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.33% and 0.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
by Abhinab Dasgupta
Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the Trump administration's healthcare policies.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ensign Group Invests in Growth With New Facility Acquisitions
by Zacks Equity Research
ENSG continues its strategic growth with new acquisitions across Washington and California.
Wall Street Analysts See a 27.25% Upside in Ensign Group (ENSG): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.3% in Ensign Group (ENSG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Ensign Group (ENSG) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments
by Zacks Equity Research
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
Humana's CenterWell Launches Gladstone Walmart Location for Seniors
by Zacks Equity Research
The easy accessibility for patients will give HUM a competitive edge over other senior-focused healthcare providers.
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health Expands Partnership With Piedmont in Georgia
by Zacks Equity Research
EHC and Piedmont expand their partnership with a new rehab hospital in Athens, enhancing patient recovery services.
Molina Healthcare Expands Presence With Illinois D-SNP Contract Win
by Zacks Equity Research
MOH secures a key Illinois contract, strengthening its foothold in the dual-eligible market.
Humana & Icon Enhance Senior Healthcare With Integrated Specialty Care
by Zacks Equity Research
HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.
Teladoc Expands Specialty Care Access With Carrum Health Partnership
by Zacks Equity Research
TDOC partners with Carrum Health in a bid to expand access to specialty care.
Here's What Brookdale's Occupancy Growth Story Tells Us
by Zacks Equity Research
BKD is likely to have witnessed 40 straight months of year-over-year increases in weighted average occupancy.
Teladoc Doubles Down on Connected Care With New Partnerships
by Zacks Equity Research
With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.
The Joint Gears Up for Q4 Earnings: Here's What to Expect
by Zacks Equity Research
JYNT's fourth-quarter results are likely to reflect higher Royalty fees, Software fees and Advertising fund revenues.
Wall Street Analysts Think Ensign Group (ENSG) Could Surge 27.4%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Ensign Group (ENSG) points to a 27.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?
by Zacks Equity Research
MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth
by Zacks Equity Research
TDOC expands weight care access with LillyDirect, boosting growth by offering affordable GLP-1 medications like Zepbound, enhancing patient outcomes and engagement.